Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study

Published on September 28, 2021

Evelo Biosciences (EVLO) reports encouraging data from a phase II study evaluating EDP1815 for the treatment of mild and moderate psoriasis. Shares up...

Continue reading on website
Other news

Announcing FlexTal + Entrepreneur 2021 Workforce Report

September 28, 2021
The workforce holds the power as companies rush to make decisions for the new normal, a report by FlexTal and Entrepreneur Media finds.

Facebook (FB) Expands Its Metaverse Initiative, to Invest $50M

September 28, 2021
Facebook (FB) is set to invest $50 million over a two-year period on metaverse initiatives through its recently introduced XR Programs and Research Fu...